Emerald Health's Metro Vancouver operation gets cultivation expansion license
Emerald Health Therapeutics has received from Health Canada its cultivation license amendment and has full municipal permitting for its first of two 78,000 square foot greenhouses at its organic Metro Vancouver site in British Columbia. With an additional 50,000 square feet and seven grow areas licensed for cultivation-related activities, Emerald can now begin commercial greenhouse production at this site. Planting will begin immediately and is expected to be completed by the end of Q4, with the first harvests planned for January 2020. This second license amendment builds on the initial site license, received in June of this year, used to propagate premium organic plant stock for this site, as well as the first amendment, received in July of this year, which added 12 acres of outdoor cultivation area. Emerald capitalized on the outdoor growing season with one growing cycle for research and development purposes and to enhance planning for the full 2020 outdoor growing season. All indoor and outdoor operations to-date have been focused on facilitating organic certification, which, pursuant to an initial inspection that took place in September, is expected imminently. The Metro Vancouver organic site encompasses 156,000 square feet in two greenhouses as well as 12 acres of licensed outdoor cultivation area. The first outdoor cannabis crop was harvested recently and Emerald also secured the harvest from an adjacent 12 acres of outdoor grow area. In this outdoor initiative, the company assessed the viability of select genetics for BC greenhouse and outdoor climates. This genetic development program has produced several new phenotypes, which will lead to greater differentiation in Emerald's product offerings. Emerald will commission the second greenhouse at its Metro Vancouver site as it more fully analyzes market preferences for the diverse products from its licensed and operational grow infrastructure at its Pure Sunfarms joint venture, Metro Vancouver, and Verdelite. Together these three operations position the Company to play a significant role in the growing Canadian medical and adult use markets. Emerald has substantially completed its capital outlays for the Metro Vancouver site, as well as for its Quebec Verdelite operation.